Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Krzysztof Bańkowski"'
Autor:
Krzysztof Bańkowski
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
SSRN Electronic Journal.
Autor:
Krzysztof Bańkowski, Othman Bouabdallah, João Domingues Semeano, Ettore Dorrucci, Maximilian Freier, Pascal Jacquinot, Wolfgang Modery, Marta Rodríguez Vives, Vilém Valenta, Nico Zorell
Publikováno v:
SSRN Electronic Journal.
Autor:
Xavier Debrun, Klaus Masuch, Isabel Vansteenkiste, M. Ferdinandusse, Leopold von Thadden, Sebastian Hauptmeier, Mario Alloza, Krzysztof Bańkowski, João Domingues Semeano, Jens Eisenschmidt, Tilman Bletzinger, Othman Bouabdallah, Gabriele Galati, Pablo Burriel, Sándor Gardó, Cristina D. Checherita-Westphal, Felix Hammermann, Stephan Krikor Haroutunian, Jacopo Cimadomo, Benjamin Hartung, Pascal Jacquinot, Christophe Kamps, Steven Poelhekke, Ivan Kataryniuk, Joost Röttger, Falk Mazelis, Stephan Sauer, Katja Schmidt, Carlos Montes-Galdón, Sebastian Schmidt, Philip Muggenthaler, Carolin Nerlich, Ralph Setzer, Galo Nuño, Vilém Valenta, Anamaria Piloiu, Guido Wolswijk, Massimiliano Pisani, Chloé Derouen, Thomas Faria, Jean Barthélemy, Dennis Bonam, Giuseppe Ferrero, José Garcia, José Cardoso da, Kai Christoffe, Tommy Kostka, Sebastiaan Pool, Julia Körding, Marzia Romanelli, Kamila Slawinska, Marco Marrazzo, Talga Ozden, Agnieszka Trzcinska, Alari Paulus, Alexandru Penciu
Publikováno v:
SSRN Electronic Journal.
Autor:
Marien Ferdinandusse, Vilém Valenta, Krzysztof Bańkowski, Sebastian Hauptmeier, Pascal Jacquinot
Publikováno v:
SSRN Electronic Journal.
In response to the economic fallout from the coronavirus (COVID-19) pandemic, the European Council agreed on the Next Generation EU (NGEU) instrument. NGEU allows the European Commission to issue debt to finance grants and loans to EU Member States,
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Advances in the Discovery and Development of Peptide Therapeutics. :186-196
Autor:
Krzysztof Bańkowski, M. Ferdinandusse, Maria Grazia Attinasi, Cristina D. Checherita-Westphal, Georgios Palaiodimos, Maria Campos
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Journal of Medicinal Chemistry. 57:5986-5994
The 99mTc-labeled conjugates of the vasopressin (AVP) peptide and of its analogue d(CH2)5[D-Tyr(Et2)-Ile4-Eda9]AVP (AVP(an)) have been synthesized using the technetium complexes with tetradentate tripodal chelator (the tris(2-mercaptoethyl)amine (NS3
Autor:
Wojciech Łuniewski, Jatczak Kamil, Kinga Trzcińska, Marta Łaszcz, Wioleta Maruszak, Krzysztof Bańkowski
Erlotinib is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR) and is used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer [1]. It is known that erlotini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfeb1b4586836a6e4edbfac325140474
https://doi.org/10.7287/peerj.preprints.1835v1
https://doi.org/10.7287/peerj.preprints.1835v1